Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Risk Mitigation and Its Impact on Pharma Marketing

  • Broadcast in Business
  • 0 comments
Pharmaguy

Pharmaguy

×  

Follow This Show

If you liked this show, you should follow Pharmaguy.

Call in to speak with the host

(347) 996-5894

h:755
s:696598
archived
A conversation with Jeff Fetterman, President and CEO of ParagonRx, about developing a Risk Evaluation and Mitigation Strategy (REMS) that clinicians will consider useful and that would raise their intent to prescribe.

Comments

 comments